{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:45:19Z","timestamp":1790959519993,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,7]]},"abstract":"<jats:p>Acute-on-chronic liver failure (ACLF) is the major cause of mortality in patients infected with the hepatitis B virus (HBV); however, early determination of the prognosis of patients with HBV-ACLF is insensitive or limited. This study aimed to analyze differentially expressed proteins in the plasma of patients with HBV-ACLF using data-independent acquisition mass spectrometry to provide a reference for short-term prognosis. Fifty HBV-ACLF patients and 15 healthy controls were enrolled in this study. Of these, 10 patients with HBV-ACLF and 5 healthy volunteers participated in data-independent acquisition-based proteomics and the potential core proteins were screened out via bioinformatics. Apolipoprotein C3 (APOC3) was selected and quantified by enzyme linked immunosorbent assays in all patients. And the area under the curve (AUC) was calculated to evaluate the value of APOC3 in the diagnosis and prognosis of patients with HBV-ACLF. A total of 247 differentially expressed proteins were identified in the serum of patients in the HBV-ACLF and normal control groups. A total of 148 proteins were upregulated and 99 proteins were downregulated in the HBV-ACLF group compared with those in the normal group. The expression level of APOC3 was 1.65\u2005\u00b1\u20050.44\u2009mg\/mL in patients with HBV-ACLF, which was obviously lower than the normal controls (2.04\u2005\u00b1\u20050.22\u2009mg\/mL) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) (AUC was 0.766, with a sensitivity of 62%, and specificity of 93.3%). The expression level of APOC3 was 1.38\u2005\u00b1\u20050.44\u2009mg\/mL in the non-survival group, which was obviously lower than the survival group (1.83\u2005\u00b1\u20050.35\u2009mg\/mL) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0001) (AUC was 0.780, with a sensitivity of 50%, and specificity of 96.7%). APOC3 is associated with short-term prognosis of patients with HBV-ACLF and can be used as a potential prognostic biomarker in patients with HBV-ACLF.<\/jats:p>","DOI":"10.1097\/md.0000000000041503","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:02:44Z","timestamp":1739217764000},"page":"e41503","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["APOC3 as a potential prognostic factor for hepatitis B virus-related acute-on-chronic liver failure"],"prefix":"10.1097","volume":"104","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjian","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunliang","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2548-2018","authenticated-orcid":false,"given":"Shan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250210","first-page":"18","article-title":"Guideline for diagnosis and treatment of liver failure.","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R2-20250210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"European Association for the Study of the Liver. EASL clinical practice guidelines on acute-on-chronic liver failure.","volume":"79","year":"2023","journal-title":"J Hepatol"},{"key":"R3-20250210","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41467-024-46047-8","article-title":"BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion.","volume":"15","author":"Yu","year":"2024","journal-title":"Nat Commun"},{"key":"R4-20250210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"key":"R5-20250210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.14309\/ajg.0000000000001748","article-title":"Acute-on-chronic liver failure clinical guidelines.","volume":"117","author":"Bajaj","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R6-20250210","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(15)00309-8","article-title":"Acute-on-chronic liver failure.","volume":"386","author":"Bernal","year":"2015","journal-title":"Lancet"},{"key":"R7-20250210","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","article-title":"Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure.","volume":"67","author":"Wu","year":"2018","journal-title":"Gut"},{"key":"R8-20250210","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.4103\/jfmpc.jfmpc_2302_20","article-title":"Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure.","volume":"10","author":"Malakar","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"R9-20250210","first-page":"1352","article-title":"Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts.","volume":"48","author":"Saliba","year":"2022","journal-title":"Intensive Care Med"},{"key":"R10-20250210","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/s-0041-1730971","article-title":"Plasma exchange in acute and acute on chronic liver failure.","volume":"41","author":"Maiwall","year":"2021","journal-title":"Semin Liver Dis"},{"key":"R11-20250210","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/TP.0000000000003550","article-title":"Liver transplantation in acute-on-chronic liver failure.","volume":"105","author":"Karvellas","year":"2021","journal-title":"Transplantation"},{"key":"R12-20250210","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/1751-2980.12074","article-title":"APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF).","volume":"14","author":"Duseja","year":"2013","journal-title":"J Dig Dis"},{"key":"R13-20250210","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.4254\/wjh.v14.i12.2025","article-title":"CLIF-SOFA and CLIF-C scores for the prognostication of acute-on-chronic liver failure and acute decompensation of cirrhosis: a systematic review.","volume":"14","author":"Rashed","year":"2022","journal-title":"World J Hepatol"},{"key":"R14-20250210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.17235\/reed.2017.4701\/2016","article-title":"CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with acute on chronic liver failure admitted to the ward.","volume":"109","author":"Barosa","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"key":"R15-20250210","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2021.05.026","article-title":"Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure.","volume":"75","author":"Li","year":"2021","journal-title":"J Hepatol"},{"key":"R16-20250210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13229-020-00334-5","article-title":"Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders.","volume":"11","author":"Murtaza","year":"2020","journal-title":"Mol Autism"},{"key":"R17-20250210","doi-asserted-by":"crossref","first-page":"e8126","DOI":"10.15252\/msb.20178126","article-title":"Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial.","volume":"14","author":"Ludwig","year":"2018","journal-title":"Mol Syst Biol"},{"key":"R18-20250210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-017-00249-5","article-title":"Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.","volume":"8","author":"Collins","year":"2017","journal-title":"Nat Commun"},{"key":"R19-20250210","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R20-20250210","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/bioinformatics\/btu305","article-title":"MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments.","volume":"30","author":"Choi","year":"2014","journal-title":"Bioinformatics"},{"key":"R21-20250210","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.2147\/IDR.S417472","article-title":"Bikunin: a promising prognostic biomarker for acute-on-chronic liver failure in patients with viral hepatitis B.","volume":"16","author":"Qin","year":"2023","journal-title":"Infect Drug Resist"},{"key":"R22-20250210","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure.","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"key":"R23-20250210","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.3390\/cells9122632","article-title":"Leukocytes, systemic inflammation and immunopathology in acute-on-chronic liver failure.","volume":"9","author":"Casulleras","year":"2020","journal-title":"Cells"},{"key":"R24-20250210","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1172\/JCI130197","article-title":"Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure.","volume":"130","author":"Wu","year":"2020","journal-title":"J Clin Invest"},{"key":"R25-20250210","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.7150\/thno.31991","article-title":"Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B.","volume":"9","author":"Sun","year":"2019","journal-title":"Theranostics"},{"key":"R26-20250210","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3892\/etm.2015.2727","article-title":"iTRAQ-based proteomic analysis of hepatic tissues from patients with hepatitis B virus-induced acute-on-chronic liver failure.","volume":"10","author":"Peng","year":"2015","journal-title":"Exp Ther Med"},{"key":"R27-20250210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12953-023-00209-6","article-title":"Data-independent acquisition-based mass spectrometry (DIA-MS) for quantitative analysis of patients with chronic hepatitis B.","volume":"21","author":"Wang","year":"2023","journal-title":"Proteome Sci"},{"key":"R28-20250210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","article-title":"Acute-on-chronic liver failure: terminology, mechanisms and management.","volume":"13","author":"Sarin","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R29-20250210","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis.","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R30-20250210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.510290504","article-title":"Differential expression of apolipoprotein E messenger RNA within the rat liver lobule determined by in situ hybridization.","volume":"29","author":"Massimi","year":"1999","journal-title":"Hepatology"},{"key":"R31-20250210","doi-asserted-by":"crossref","first-page":"106376","DOI":"10.1016\/j.phrs.2022.106376","article-title":"Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis.","volume":"183","author":"Ren","year":"2022","journal-title":"Pharmacol Res"},{"key":"R32-20250210","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1007\/s00277-023-05518-6","article-title":"Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study.","volume":"102","author":"Zewinger","year":"2023","journal-title":"Ann Hematol"},{"key":"R33-20250210","first-page":"2748","article-title":"Apolipoprotein deficiency and chronic liver disease.","volume":"49","author":"Shah","year":"2001","journal-title":"J Assoc Physicians India"},{"key":"R34-20250210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1476-511X-13-130","article-title":"Investigation into the effect of hepatitis B virus on apoliprotein A1 expression and its mechanism.","volume":"13","author":"Jiang","year":"2014","journal-title":"Lipids Health Dis"},{"key":"R35-20250210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1476-511X-10-207","article-title":"HBV inhibits apoB production via the suppression of MTP expression.","volume":"10","author":"Wang","year":"2011","journal-title":"Lipids Health Dis"},{"key":"R36-20250210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12944-017-0607-2","article-title":"Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3.","volume":"16","author":"Zhu","year":"2017","journal-title":"Lipids Health Dis"},{"key":"R37-20250210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation.","volume":"21","author":"Schmit","year":"2020","journal-title":"Nat Immunol"},{"key":"R38-20250210","doi-asserted-by":"crossref","first-page":"793405","DOI":"10.3389\/fcvm.2022.793405","article-title":"Plasma proteome profiling of patients with in-stent restenosis by tandem mass tag-based quantitative proteomics approach.","volume":"9","author":"Hou","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R39-20250210","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.24571","article-title":"Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.","volume":"54","author":"Lee","year":"2011","journal-title":"Hepatology"},{"key":"R40-20250210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12026-023-09379-z","article-title":"Silencing ApoC3 alleviates LPS-induced acute lung injury by inhibiting TLR signaling pathway.","volume":"71","author":"Qi","year":"2023","journal-title":"Immunol Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:02:57Z","timestamp":1739217777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041503","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}